基于GASTRODATA登记的欧洲胃癌胃切除术后并发症发生率与分级:一项回顾性观察研究
总体并发症发生率为29.8%,最常见为非手术感染(23%)和吻合口漏(9.8%);中位Clavien-Dindo分级为IIIa,住院、30天和90天死亡率分别为3.2%、3.6%和4.5%。
要点
- 胃癌胃切除术后总体并发症发生率为29.8%,中位Clavien-Dindo分级为IIIa。
- 最常见并发症为非手术感染(23%)和吻合口漏(9.8%)。
- 住院、30天和90天死亡率分别为3.2%、3.6%和4.5%。
核心结论
- 基于标准化平台收集的欧洲数据显示,胃癌胃切除术仍伴随较高的并发症发生率和死亡率。
- 需要采取措施限制最常见和最致命并发症的发生并有效治疗。
研究设计与样本
- 欧洲11国胃癌转诊中心参与的回顾性观察研究,使用GASTRODATA在线平台记录数据。
- 纳入2年期间连续胃切除术患者共1349例,记录临床、肿瘤学、手术数据及出院时、术后30天和90天结局。
主要发现
- 总体并发症发生率为29.8%,402例患者共发生625例次并发症。
- 最常见并发症为非手术感染(23%)、吻合口漏(9.8%)、引流液异常或腹腔积液(9.3%)、胸腔积液(8.3%)、术后出血(5.6%)及需侵入性治疗的其他主要并发症(5.6%)。
- 中位Clavien-Dindo评分为IIIa,综合并发症指数中位数为26.2。
- 住院死亡率3.2%,30天死亡率3.6%,90天死亡率4.5%。
关键数值与推荐
- 采用新开发的27项统一定义的并发症列表进行标准化记录。
- 新辅助化疗患者577例(42.8%);全胃切除术占46.1%,次全胃切除术占46.4%。
- 近80%的手术实施了D2或D2+淋巴结清扫。
临床怎么用
- 可采用GASTRODATA标准化并发症定义与分级体系记录胃癌胃切除术后结局。
- 应重点关注非手术感染和吻合口漏等高频并发症的预防与处理。
- 术后监测需覆盖至90天以全面评估死亡风险。
局限性
- 本研究为回顾性观察研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Utilizing a standardized dataset based on a newly developed list of 27 univocally defined complications, this study analyzed data to assess the incidence and grading of complications and evaluate outcomes associated with gastrectomy for cancer in Europe. SUMMARY BACKGROUND DATA: The absence of a standardized system for recording gastrectomy-associated complications makes it difficult to compare results from different hospitals and countries. METHODS: Using a secure online platform (www.gastrodata.org), referral centers for gastric cancer in 11 European countries belonging to the Gastrectomy Complications Consensus Group recorded clinical, oncological, and surgical data, and outcome measures at hospital discharge and at 30 and 90 days postoperatively. This retrospective observational study included all consecutive resections over a 2-year period. RESULTS: A total of 1349 gastrectomies performed between January 2017 and December 2018 were entered into the database. Neoadjuvant chemotherapy was administered to 577 patients (42.8%). Total (46.1%) and subtotal (46.4%) gastrectomy were the predominant resections. D2 or D2+ lymphadenectomy was performed in almost 80% of operations. The overall complications' incidence was 29.8%; 402 patients developed 625 complications, with the most frequent being nonsurgical infections (23%), anastomotic leak (9.8%), other postoperative abnormal fluid from drainage and/or abdominal collections (9.3%), pleural effusion (8.3%), postoperative bleeding (5.6%), and other major complications requiring invasive treatment (5.6%). The median Clavien-Dindo score and Comprehensive Complications Index were IIIa and 26.2, respectively. In-hospital, 30-day, and 90-day mortality were 3.2%, 3.6%, and 4.5%, respectively. CONCLUSIONS: The use of a standardized platform to collect European data on perioperative complications revealed that gastrectomy for gastric cancer is still associated with heavy morbidity and mortality. Actions are needed to limit the incidence of, and to effectively treat, the most frequent and most lethal complications.
引用
- Baiocchi GL, Giacopuzzi S, Reim D, et al. Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study. Ann Surg. 2020. PMID: 32925254. doi:10.1097/SLA.0000000000004341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。